List Title | APhA DrugInfoLine

Neurology

SORT BY: Most Recent Most Viewed

July 30, 2018

Fingolimod and dimethyl fumarate appear to have similar efficacy for MS

READ

PREVIEW
Use of fingolimod (Gilenya—Novartis) or delayed-release dimethyl fumarate (Tecfidera—Biogen) for patients with relapsing-remitting multiple sclerosis (RRMS) appears to have similar efficacy for...
June 19, 2018

Updated guideline released on use of disease-modifying therapies for patients with MS

READ

PREVIEW
In April 2018, the American Academy of Neurology (AAN) published an updated guideline in Neurology on the use of disease-modifying agents for patients with multiple sclerosis (MS). The...
June 4, 2018

Teratogenic risk of antiepileptic drugs assessed

READ

PREVIEW
A prospective analysis of data from a European pregnancy registry of antiepileptic drugs published in Lancet Neurology showed that use of valproate had the highest prevalence of major...
January 9, 2018

Two novel treatments show promise in preventive treatment of migraines

READ

PREVIEW
Two investigational monoclonal antibodies that target either the calcitonin gene-related peptide (CGRP) receptor (i.e., erenumab) or CGRP itself (i.e., fremanezumab) were shown to be effective for...
December 26, 2017

Caffeine is not effective for management of Parkinson disease symptoms

READ

PREVIEW
Use of caffeine capsules by patients with Parkinson disease (PD) did not result in any significant improvement compared with placebo for motor parkinsonism or motor signs or symptoms, and it was...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.